MENU
IDXG
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Interpace Biosciences (IDXG) Ownership - Who owns Interpace Biosciences?

Profile

Industry
Servicestothe Health Industry
Address
300 Interpace Parkway
Phone
+1 855 776-6419
Employees
94
Web
https://www.interpace.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
8.62M
P/E Ratio
N/A
Total Cash
5.6M
Projected Growth
N/A
Total Debt
15.62M
Revenue
33.74M
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
7.91 USD as % of share price

Fundamentals

IDXG
Capitalization
8.62M
P/E Ratio
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
5.6M
Total Cash/Share
1.30
Total Debt
15.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.91%
Revenue
33.7M
ROE
N/A
Book Value
-62.54M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-4.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
405K
Current Ratio
0.90
Current Revenue Per Employee
104531.91
Dividends Per Share - Security
N/A
EBITDA
-1.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.84
Revenue To Assets
-71.39
Shares Held By Institutions
48
Shares Outstanding - Current
4.31M
Total Liabilities
78.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
186.111
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of commercialization services to biopharmaceutical companies

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
300 Interpace Parkway
Phone
+1 855 776-6419
Employees
94
Web
https://www.interpace.com